Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
138.07
+7.22 (5.52%)
Oct 31, 2025, 4:00 PM EDT
Merck KGaA Revenue
Merck KGaA had revenue of 5.26B EUR in the quarter ending June 30, 2025, a decrease of -1.81%. This brings the company's revenue in the last twelve months to 21.22B, up 1.67% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.22B EUR
Revenue Growth
+1.67%
P/S Ratio
2.28
Revenue / Employee
359.52K EUR
Employees
59,020
Market Cap
56.89B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Merck KGaA News
- 4 days ago - MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies - Financial Post
- 8 days ago - Merck KGaA: An AI-Resistant Pharma Play - Seeking Alpha
- 9 days ago - Merck KGaA (MKKGY) Analyst/Investor Day - Slideshow - Seeking Alpha
- 15 days ago - Merck KGaA Reaches Deal With U.S. To Cut Prices On IVF Drugs - Nasdaq
- 15 days ago - Merck KGaA (MKGAF) Offers Major IVF Discount in New US Deal - GuruFocus
- 16 days ago - Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs. - MarketWatch
- 16 days ago - Trump announces efforts to expand access to IVF drugs - CNBC
- 16 days ago - Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets - WSJ